Importer of Controlled Substances Application: Xcelience, 36946 [2019-16168]
Download as PDF
<![CDATA[
36946
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 31, 2019, Catalent
Pharma Solutions, LLC, 3031 Red Lion
Road, Philadelphia, Pennsylvania 19114
applied to be registered as an importer
of the following basic class of controlled
substance:
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric Acid.
Drug
code
Schedule
2010
I
The company plans to import finished
dosage unit products containing gamma-
hydroxybutyric acid for clinical trials,
research, and analytical activities.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16166 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Xcelience
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 29, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 29, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on May 2,
2019, Xcelience, 4901 West Grace
Street, Tampa, Florida 33607, applied to
be registered as an importer of the
following basic class of controlled
substance:
Controlled substance
Drug code
Amphetamine .........................................................................................................................................................
The company plans to import the
listed controlled substance in finished
dosage form for clinical trials, research
and analytical purposes.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16168 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 29, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 29, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Nostrum Laboratories,
Inc.
ACTION:
Notice of application.
1100
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on March
13, 2019, Nostrum Laboratories, Inc.,
705 East Mulberry Street, Bryan, Ohio
43506 applied to be registered as an
importer of the following basic class of
controlled substance:
Drug code
jspears on DSK3GMQ082PROD with NOTICES
Marihuana Extract ..................................................................................................................................................
Marihuana ..............................................................................................................................................................
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
PO 00000
Frm 00063
Fmt 4703
II
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Controlled substance
The company plans to import the
listed controlled substances for research
and new drug development. Approval of
permit applications will occur only
when the registrant’s business activity is
Schedule
Sfmt 9990
7350
7360
Schedule
I
I
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16173 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Page 36946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16168]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Xcelience
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 29, 2019.
Such persons may also file a written request for a hearing on the
application on or before August 29, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on May 2,
2019, Xcelience, 4901 West Grace Street, Tampa, Florida 33607, applied
to be registered as an importer of the following basic class of
controlled substance:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amphetamine...................... 1100 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance in
finished dosage form for clinical trials, research and analytical
purposes.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16168 Filed 7-29-19; 8:45 am]
BILLING CODE 4410-09-P
